MMTC Limited has informed the Exchange regarding Press Release issued by DIPAM. regarding Disinvestment of Neelachal Ispat Nigam Ltd - a JV company of MMTC Ltd.
Navneet Education Limited has informed the Exchange about Copy of Newspaper Publication. Copy of published Un-audited results For Quarter and Six Months ended 30th September, 2021
AstraZeneca Pharma India Limited has informed the Exchange that Ms. Kimsuka Narsimhan (DIN: 02102783), Independent Director of the Company, retired as Director of the Company, upon completion of her term of office, at the close of business hours on February 1, 2022.
Solara Active Pharma Sciences Limited has informed the Exchange about Schedule of meet
Heranba Industries Limited has informed the Exchange about Schedule of meet
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Mr. Sanjiv Kumar Dudeja as Chief Financial Officer of the company w.e.f. February 01, 2022.
Meghmani Finechem Limited has informed the Exchange about Schedule of meet
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Intimation for Updation in Website.
Indusind Bank Limited has informed the Exchange about Schedule of meet
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
